Sabra Healthcare REIT (SBRA) Ratios
Sabra Healthcare REIT Ratios
MX:SBRA's free cash flow for Q2 2026 was $60.66M. For the 2026 fiscal year, MX:SBRA's free cash flow was decreased by $-25.16M and operating cash flow was $85.82M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.56 | 0.88 | 0.78 | 0.59 | 1.78 |
| Quick Ratio | 0.56 | 0.88 | 0.78 | 0.59 | 1.78 |
| Cash Ratio | 0.21 | 0.27 | 0.18 | 0.15 | 0.78 |
| Solvency Ratio | 0.13 | 0.12 | 0.08 | 0.04 | 0.03 |
| Operating Cash Flow Ratio | 1.03 | 1.38 | 1.30 | 0.93 | 2.49 |
| Short-Term Operating Cash Flow Coverage | 1.60 | 2.91 | 3.18 | 1.60 | 0.00 |
| Net Current Asset Value | $ -2.48B | $ -2.36B | $ -2.40B | $ -2.49B | $ -2.33B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.46 | 0.46 | 0.45 | 0.44 | 0.41 |
| Debt-to-Equity Ratio | 0.90 | 0.89 | 0.87 | 0.83 | 0.72 |
| Debt-to-Capital Ratio | 0.47 | 0.47 | 0.47 | 0.45 | 0.42 |
| Long-Term Debt-to-Capital Ratio | 0.45 | 0.46 | 0.45 | 0.43 | 0.41 |
| Financial Leverage Ratio | 1.95 | 1.93 | 1.92 | 1.88 | 1.77 |
| Debt Service Coverage Ratio | 1.38 | 1.86 | 1.49 | 0.71 | 1.67 |
| Interest Coverage Ratio | 2.35 | 2.23 | 1.96 | 2.23 | 2.14 |
| Debt to Market Cap | 0.55 | 0.60 | 0.73 | 0.87 | 0.81 |
| Interest Debt Per Share | 11.03 | 10.96 | 11.07 | 11.49 | 11.61 |
| Net Debt to EBITDA | 5.43 | 5.78 | 7.71 | 11.53 | 14.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 65.00% | 67.71% | 69.85% | 73.97% | 75.21% |
| EBIT Margin | 34.83% | 34.55% | 19.88% | 4.66% | -2.24% |
| EBITDA Margin | 58.97% | 58.67% | 48.15% | 34.71% | 29.18% |
| Operating Profit Margin | 34.06% | 36.55% | 34.24% | 37.59% | 37.00% |
| Pretax Profit Margin | 20.31% | 18.16% | 2.43% | -12.22% | -19.56% |
| Net Profit Margin | 20.09% | 18.02% | 2.12% | -12.42% | -19.89% |
| Continuous Operations Profit Margin | 20.08% | 18.02% | 2.12% | -12.42% | -19.89% |
| Net Income Per EBT | 98.90% | 99.21% | 87.30% | 101.63% | 101.66% |
| EBT Per EBIT | 59.63% | 49.69% | 7.11% | -32.52% | -52.86% |
| Return on Assets (ROA) | 2.83% | 2.39% | 0.26% | -1.35% | -1.90% |
| Return on Equity (ROE) | 5.51% | 4.62% | 0.49% | -2.54% | -3.35% |
| Return on Capital Employed (ROCE) | 5.12% | 5.06% | 4.30% | 4.34% | 3.62% |
| Return on Invested Capital (ROIC) | 4.85% | 4.92% | 3.69% | 4.19% | 3.62% |
| Return on Tangible Assets | 2.87% | 2.40% | 0.26% | -1.36% | -1.92% |
| Earnings Yield | 3.40% | 3.13% | 0.42% | -2.70% | -3.82% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.96 | 5.34 | 4.84 | 4.22 | 4.12 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.14 | 0.13 | 0.12 | 0.11 | 0.10 |
| Working Capital Turnover Ratio | -8.91 | -18.21 | -6.88 | -47.34 | 10.26 |
| Cash Conversion Cycle | 52.44 | 68.38 | 75.43 | 86.40 | 88.51 |
| Days of Sales Outstanding | 52.44 | 68.38 | 75.43 | 86.40 | 88.51 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 52.44 | 68.38 | 75.43 | 86.40 | 88.51 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.44 | 1.33 | 1.30 | 1.37 | 1.63 |
| Free Cash Flow Per Share | 1.44 | 1.33 | 1.30 | 1.37 | 1.47 |
| Dividend Paid and CapEx Coverage Ratio | 1.20 | 1.11 | 1.08 | 1.14 | 1.20 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 10.60 |
| Operating Cash Flow Coverage Ratio | 0.14 | 0.13 | 0.12 | 0.12 | 0.15 |
| Operating Cash Flow to Sales Ratio | 0.45 | 0.44 | 0.46 | 0.51 | 0.63 |
| Free Cash Flow Yield | 7.63% | 7.68% | 9.11% | 11.00% | 10.88% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 29.59 | 32.07 | 239.84 | -36.99 | -26.19 |
| Price-to-Sales (P/S) Ratio | 5.90 | 5.75 | 5.10 | 4.59 | 5.21 |
| Price-to-Book (P/B) Ratio | 1.62 | 1.48 | 1.18 | 0.94 | 0.88 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.11 | 13.02 | 10.98 | 9.09 | 9.19 |
| Price-to-Operating Cash Flow Ratio | 13.11 | 13.02 | 10.98 | 9.09 | 8.32 |
| Price-to-Earnings Growth (PEG) Ratio | 1.60 | 0.04 | -2.04 | 1.07 | 0.15 |
| Enterprise Value Multiple | 15.43 | 15.58 | 18.30 | 24.76 | 31.88 |
| Enterprise Value | 7.05B | 6.43B | 5.70B | 5.37B | 5.30B |
| EV to EBITDA | 15.43 | 15.58 | 18.30 | 24.76 | 31.88 |
| EV to Sales | 9.10 | 9.14 | 8.81 | 8.60 | 9.30 |
| EV to Free Cash Flow | 20.22 | 20.70 | 18.98 | 17.01 | 16.41 |
| EV to Operating Cash Flow | 20.22 | 20.70 | 18.98 | 17.01 | 14.87 |
| Tangible Book Value Per Share | 11.43 | 11.62 | 11.99 | 13.06 | 15.18 |
| Shareholders’ Equity Per Share | 11.69 | 11.74 | 12.12 | 13.23 | 15.43 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.01 | 0.13 | -0.02 | -0.02 |
| Revenue Per Share | 3.21 | 3.01 | 2.80 | 2.71 | 2.60 |
| Net Income Per Share | 0.64 | 0.54 | 0.06 | -0.34 | -0.52 |
| Tax Burden | 0.99 | 0.99 | 0.87 | 1.02 | 1.02 |
| Interest Burden | 0.58 | 0.53 | 0.12 | -2.62 | 8.72 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 2.24 | 2.45 | 21.85 | -4.07 | -3.15 |
Currency in USD